I. Project Objectives & IP Strategy
The Clinical Target
AS affects roughly 1 in 150 people globally, with a significant subset progressing to severe spinal fusion and structural deformity. Current orthopedic solutions rely on rigid, non-adaptive hardware.
33med targets the materials science (biocompatibility, titanium load limits), surgical kinematics, and localized biological suppression necessary for total spinal arthroplasty.
IP Generation & Licensing
The core AI architecture remains strictly proprietary. The engine is utilized to generate mathematically proven, simulation-backed hypotheses for advanced spinal implants.
The objective is to file provisional patents based on these localized computational models, subsequently licensing the explicit Intellectual Property to major medical device manufacturers.
II. Technology Architecture
1% Orchestration
A custom, multi-tenant, asynchronous AI operating system capable of executing hours-long, complex tasks without human intervention.
- / Graph-Native Grounding
- / Dynamic Tool Retrieval
- / State Hydration
Actor-Critic Swarms
Utilizing "Plan-and-Solve" directed pathways. An Actor-Critic swarm executes multi-pass generations, forcing the AI to perform its own QA.
- / Multi-agent cross-validation
- / Automated self-correction
- / Horizon checkpointing
Deterministic Sandboxes
Agents output strictly typed JSON to interact with headless scientific simulators via network-isolated micro-sandboxes.
- / Native 3D Graph Neural Nets
- / OpenMM Integration
- / AlphaFold Processing
III. Team & Advisory
Ben Gervais
Principal Architect & CEO
17+ years scaling enterprise AI pipelines and complex data architectures. Designed the 1% Orchestration Engine. Diagnosed with AS 22 years ago (90% spinal fusion), driving the strict engineering parameters of the project.
John Hubble
Hardware & Kinematics Lead
25+ years of end-to-end hardware innovation in defense, medical devices, and exoskeletal robotics. Expertise in additive manufacturing, CNC mapping, and transferring designs into high-end Asian manufacturing ecosystems.
Dr. Lee Chen
Clinical Advisory Lead
MD-credentialed orthopedic specialist based in Taiwan. Facilitates direct clinical validation pathways with senior reconstructive surgeons at National Taiwan University Hospital (NTUH) and Chang Gung Memorial Hospital, steering anatomical precision and surgical safety boundaries.
IV. Project Inquiries
We are actively engaging with select research syndicates, clinical advisors, and industry development partners to accelerate our biomechanical simulation pipelines and expand our portfolio of IP candidates. If you wish to learn more about our methodologies, technical roadmap, or potential collaborative alignments, contact the laboratory directors.